Table 5 Studies comparing remote home monitoring (dedicated monitoring devices) to no remote home monitoring
Studies comparing RHM (dedicated monitoring devices) to no RHM | |||||
|---|---|---|---|---|---|
Outcomes | № of participants (studies) | Certainty of the evidence (GRADE) | Relative effect* (95% CI) | Anticipated absolute effects | |
Risk with no RHM | Risk difference with RHM (dedicated monitoring devices) | ||||
COPD Assessment Test (CAT) scores at the end of monitoring period | 62 (1 RCT) | ⨁⨁◯◯ LOW a,b | not pooled | not pooled | not pooled |
Patient experience- Overall satisfaction at the end of monitoring period | 111 (3 RCTs) | ⨁⨁◯◯ LOW a,b | not pooled | not pooled | not pooled |
Patient experience- Overall satisfaction at the end of monitoring period | 69 (1 observational study) | ⨁◯◯◯ VERY LOW b,c | not pooled | not pooled | not pooled |
Average number of exacerbations | 62 (1 RCT) | ⨁⨁◯◯ LOW a,b | not pooled | not pooled | not pooled |
Average number of exacerbations | 1238 (1 observational study) | ⨁◯◯◯ VERY LOW c | not pooled | not pooled | not pooled |
Average number of ER visits due to COPD | 302 (4 RCTs) | ⨁⨁◯◯ LOW a,b | not pooled | not pooled | not pooled |
Average number of hospital admissions due to COPD | 353 (5 RCTs) | ⨁⨁◯◯ LOW a,b | not pooled | not pooled | not pooled |
Average number of hospital admissions due to COPD | 1238 (1 observational study) | ⨁◯◯◯ VERY LOW c | not pooled | not pooled | not pooled |
Adherence as the proportion of participants who completed the study | 707 (7 RCTs) | ⨁⨁◯◯ LOW a,d | not pooled | not pooled | not pooled |